Pharmacologic treatment of cognition in Alzheimer's dementia

Martin R. Farlow, Rebecca M. Evans

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Much of the treatment research and development for Alzheimer's disease (AD) in recent years has been based on the cholinergic hypothesis. Cholinesterase inhibition has been shown to improve the symptoms of mild to moderate AD. Two cholinesterase inhibitors (CIs) are now available and two more may be available shortly. Free radical inhibitors, estrogen, and anti- inflammatory drugs may also delay the onset and slow progression of AD. Combination therapies employing CIs and these other drugs may prove successful in the future.

Original languageEnglish (US)
Pages (from-to)S36-S44
JournalNeurology
Volume51
Issue number1 SUPPL.
StatePublished - Aug 5 1998

Fingerprint

Cognition
Alzheimer Disease
Cholinesterase Inhibitors
Cholinesterases
Pharmaceutical Preparations
Cholinergic Agents
Free Radicals
Estrogens
Anti-Inflammatory Agents
Research
Therapeutics
Inhibition (Psychology)

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pharmacologic treatment of cognition in Alzheimer's dementia. / Farlow, Martin R.; Evans, Rebecca M.

In: Neurology, Vol. 51, No. 1 SUPPL., 05.08.1998, p. S36-S44.

Research output: Contribution to journalArticle

Farlow, MR & Evans, RM 1998, 'Pharmacologic treatment of cognition in Alzheimer's dementia', Neurology, vol. 51, no. 1 SUPPL., pp. S36-S44.
Farlow, Martin R. ; Evans, Rebecca M. / Pharmacologic treatment of cognition in Alzheimer's dementia. In: Neurology. 1998 ; Vol. 51, No. 1 SUPPL. pp. S36-S44.
@article{b3cedaa9481642919be4440168dea0c8,
title = "Pharmacologic treatment of cognition in Alzheimer's dementia",
abstract = "Much of the treatment research and development for Alzheimer's disease (AD) in recent years has been based on the cholinergic hypothesis. Cholinesterase inhibition has been shown to improve the symptoms of mild to moderate AD. Two cholinesterase inhibitors (CIs) are now available and two more may be available shortly. Free radical inhibitors, estrogen, and anti- inflammatory drugs may also delay the onset and slow progression of AD. Combination therapies employing CIs and these other drugs may prove successful in the future.",
author = "Farlow, {Martin R.} and Evans, {Rebecca M.}",
year = "1998",
month = "8",
day = "5",
language = "English (US)",
volume = "51",
pages = "S36--S44",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Pharmacologic treatment of cognition in Alzheimer's dementia

AU - Farlow, Martin R.

AU - Evans, Rebecca M.

PY - 1998/8/5

Y1 - 1998/8/5

N2 - Much of the treatment research and development for Alzheimer's disease (AD) in recent years has been based on the cholinergic hypothesis. Cholinesterase inhibition has been shown to improve the symptoms of mild to moderate AD. Two cholinesterase inhibitors (CIs) are now available and two more may be available shortly. Free radical inhibitors, estrogen, and anti- inflammatory drugs may also delay the onset and slow progression of AD. Combination therapies employing CIs and these other drugs may prove successful in the future.

AB - Much of the treatment research and development for Alzheimer's disease (AD) in recent years has been based on the cholinergic hypothesis. Cholinesterase inhibition has been shown to improve the symptoms of mild to moderate AD. Two cholinesterase inhibitors (CIs) are now available and two more may be available shortly. Free radical inhibitors, estrogen, and anti- inflammatory drugs may also delay the onset and slow progression of AD. Combination therapies employing CIs and these other drugs may prove successful in the future.

UR - http://www.scopus.com/inward/record.url?scp=0031880348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031880348&partnerID=8YFLogxK

M3 - Article

C2 - 9674761

AN - SCOPUS:0031880348

VL - 51

SP - S36-S44

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 1 SUPPL.

ER -